Patent ID: 8541443

Claim:
Form II crystals of N 1 -(5-chloropyridin-2-yl)-N 2 -((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide p-toluenesulfonate monohydrate represented by the following formula (I): comprising peaks at diffraction angles (2θ) of 13.9±0.2, 14.2±0.2, 15.8±0.2, 16.2±0.2, 18.2±0.2, 21.5±0.2, 22.0±0.2, 22.3±0.2, 23.2±0.2, and 24.3±0.2(°) in powder x-ray diffraction obtained using Cu-Kα rays.